BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/19/2023 6:39:30 AM | Browse: 727 | Download: 1563
Publication Name World Journal of Orthopedics
Manuscript ID 83887
Country Russia
ISSN 2218-5836 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Rheumatology
Manuscript Type Observational Study
Article Title Chondroitin sulfate and glucosamine combination in patients with knee and hip osteoarthritis: A long-term observational study in Russia
Manuscript Source Unsolicited Manuscript
All Author List Alexander M Lila, Lyudmila I Alekseeva, Andrey A Baranov, Elena A Taskina, Natalya G Kashevarova, Natalia A Lapkina and Evgeny A Trofimov
ORCID
Author(s) ORCID Number
Alexander M Lila http://orcid.org/0000-0002-6068-3080
Lyudmila I Alekseeva http://orcid.org/0000-0002-8931-4991
Andrey A Baranov http://orcid.org/0000-0001-7847-1679
Elena A Taskina http://orcid.org/0000-0001-8218-3223
Natalya G Kashevarova http://orcid.org/0000-0001-8732-2720
Natalia A Lapkina http://orcid.org/0000-0003-2692-399X
Evgeny A Trofimov http://orcid.org/0000-0003-3236-4485
Funding Agency and Grant Number
Corresponding Author Elena A Taskina, MD, PhD, Senior Researcher, Bone and Joints Metabolic Diseases Laboratory, Research Institute of Rheumatology named after VA Nasonova, Kashirskoe av., 34/1, Moscow 115522, Moscow, Russia. elena.taskina.msk@gmail.com
Key Words Glucosamine; Chondroitin sulfate; Knee osteoarthritis; Hip osteoarthritis; Knee injury and osteoarthritis outcome score; Hip disability and osteoarthritis outcome score
Core Tip Long-term 64-wk treatment by oral capsules of glucosamine hydrochloride 500 mg and chondroitin sulfate 400 mg three times a day for the first 3 wk, then twice daily, was associated with clinically significant improvements in all subscale scores (Pain, Symptoms, Function, and Quality of Life) of the Knee Injury and Osteoarthritis Outcome Score/Hip Disability and Osteoarthritis Outcome Score and a decreasing number of patients with knee and hip osteoarthritis receiving any non-steroidal anti-inflammatory drugs in real-world clinical practice. Incidence of drug-related adverse events was low, and their nature was consistent with known safety profile of glucosamine hydrochloride and chondroitin sulfate combination.
Publish Date 2023-06-19 06:39
Citation Lila AM, Alekseeva LI, Baranov AA, Taskina EA, Kashevarova NG, Lapkina NA, Trofimov EA. Chondroitin sulfate and glucosamine combination in patients with knee and hip osteoarthritis: A long-term observational study in Russia. World J Orthop 2023; 14(6): 443-457
URL https://www.wjgnet.com/2218-5836/full/v14/i6/443.htm
DOI https://dx.doi.org/10.5312/wjo.v14.i6.443
Full Article (PDF) WJO-14-443-with-cover.pdf
Full Article (Word) WJO-14-443.docx